We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Product
Advertisement

One - Stop Research Support for CAR - NK Therapy

One - Stop Research Support for CAR - NK Therapy


CARNK cell therapies are novel therapeutic options developed with the aim to overcome some limitations of CART cell therapies, such as therapy induced side effects. CARNK cells exhibit higher cytolytic activity than memory T cells and untransduced NK cells; thus, being more effective in killing tumor cells. Currently, over 800 CART and 28 CARNK cell clinical trials are being conducted worldwide.

As a global leading supplier of bioreagents and CRO services for the biopharmaceutical field, Sino

Biological provides comprehensive solutions for CARNK cell therapy development. Our reagents and services can support our customers from early target discovery to the preclinical phase of research and development.


About Sino Biological
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.